Loading clinical trials...
Loading clinical trials...
The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utiliz...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
NCT06138587 · Acute Myeloid Leukemia, Leukemia, and more
NCT07445984 · Chronic Leukemia, Acute Leukemia, and more
NCT06315309 · GVHD,Acute, Acute Leukemia, and more
NCT00935090 · Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, and more
NCT01137825 · Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, and more
Stanford University School of Medicine
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions